iCAD Shares Climb After 4Q Sales Guidance Beats Expectations

Dow Jones

01-28

By Owen Tucker-Smith

iCAD shares jumped after the company issued fourth-quarter sales guidance ahead of Wall Street expectations.

Shares of the medical-device manufacturer were up 17% to $2.82 in Monday trading. The stock price is sitting above its 52-week high and has more than doubled over the past six months.

The company said it expects fourth-quarter revenue between $5.1 million and $5.3 million. Analysts surveyed by FactSet expected $4.5 million. The new guidance would represent a sales jump of between 8.5% and 12.8% from a year ago, when sales came in at $4.7 million.

The Nashua, N.H., company noted that it closed 106 deals in the fourth quarter, 19 of which were cloud deals with new and established customers.

iCAD, which develops AI-powered technology to detect breast cancer, said it would present at the 12th Annual MedTech, Digital Health, Life Science and Diagnostic Tools Conference taking place in Snowbird, Utah, in February.

Write to Owen Tucker-Smith at owen.tucker-smith@wsj.com

(END) Dow Jones Newswires

January 27, 2025 14:12 ET (19:12 GMT)

Copyright (c) 2025 Dow Jones & Company, Inc.

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

1
2
3
4
5
6
7
8
9
10

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/news/2506586089"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2506586089\",edition:\"fundamental\",,,undefined,":{"share":"https://ttm.financial/m/news/2506586089?lang=zh_TW&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-01-28 03:12","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2506586089","market":"other","top_or_hot":-1,"title":"iCAD Shares Climb After 4Q Sales Guidance Beats Expectations","media":"Dow Jones","content":"<font class=\"NormalMinus1\" face=\"Arial\">\n<pre>\n \n</pre>\n<p>\n  By Owen Tucker-Smith \n</p>\n<pre>\n \n</pre>\n<p>\n  iCAD shares jumped after the company issued fourth-quarter sales guidance ahead of Wall Street expectations. \n</p>\n<p>\n  Shares of the medical-device manufacturer were up 17% to $2.82 in Monday trading. The stock price is sitting above its 52-week high and has more than doubled over the past six months. \n</p>\n<p>\n  The company said it expects fourth-quarter revenue between $5.1 million and $5.3 million. Analysts surveyed by FactSet expected $4.5 million. The new guidance would represent a sales jump of between 8.5% and 12.8% from a year ago, when sales came in at $4.7 million. \n</p>\n<p>\n  The Nashua, N.H., company noted that it closed 106 deals in the fourth quarter, 19 of which were cloud deals with new and established customers. \n</p>\n<p>\n  iCAD, which develops AI-powered technology to detect breast cancer, said it would present at the 12th Annual MedTech, Digital Health, Life Science and Diagnostic Tools Conference taking place in Snowbird, Utah, in February. \n</p>\n<pre>\n \n</pre>\n<p>\n  Write to Owen Tucker-Smith at owen.tucker-smith@wsj.com \n</p>\n<pre>\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  January 27, 2025 14:12 ET (19:12 GMT)\n</p>\n<p>\n  Copyright (c) 2025 Dow Jones &amp; Company, Inc.\n</p>\n</font>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>iCAD Shares Climb After 4Q Sales Guidance Beats Expectations</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\niCAD Shares Climb After 4Q Sales Guidance Beats Expectations\n</h2>\n<h4 class=\"meta\">\n<div class=\"head\" \">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time smaller\">2025-01-28 03:12</p>\n</div>\n</div>\n</h4>\n</header>\n<article>\n<font class=\"NormalMinus1\" face=\"Arial\">\n<pre>\n \n</pre>\n<p>\n  By Owen Tucker-Smith \n</p>\n<pre>\n \n</pre>\n<p>\n  iCAD shares jumped after the company issued fourth-quarter sales guidance ahead of Wall Street expectations. \n</p>\n<p>\n  Shares of the medical-device manufacturer were up 17% to $2.82 in Monday trading. The stock price is sitting above its 52-week high and has more than doubled over the past six months. \n</p>\n<p>\n  The company said it expects fourth-quarter revenue between $5.1 million and $5.3 million. Analysts surveyed by FactSet expected $4.5 million. The new guidance would represent a sales jump of between 8.5% and 12.8% from a year ago, when sales came in at $4.7 million. \n</p>\n<p>\n  The Nashua, N.H., company noted that it closed 106 deals in the fourth quarter, 19 of which were cloud deals with new and established customers. \n</p>\n<p>\n  iCAD, which develops AI-powered technology to detect breast cancer, said it would present at the 12th Annual MedTech, Digital Health, Life Science and Diagnostic Tools Conference taking place in Snowbird, Utah, in February. \n</p>\n<pre>\n \n</pre>\n<p>\n  Write to Owen Tucker-Smith at owen.tucker-smith@wsj.com \n</p>\n<pre>\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  January 27, 2025 14:12 ET (19:12 GMT)\n</p>\n<p>\n  Copyright (c) 2025 Dow Jones &amp; Company, Inc.\n</p>\n</font>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":null,"symbol_name":null,"start_time":0,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","article_id":"2506586089","we_media_id":"106","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2506586089","pubTimestamp":1738005120,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Dow Jones","introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"summary":"iCAD shares jumped after the company issued fourth-quarter sales guidance ahead of Wall Street expectations.Shares of the medical-device manufacturer were up 17% to $2.82 in Monday trading. The stock price is sitting above its 52-week high and has more than doubled over the past six months.The company said it expects fourth-quarter revenue between $5.1 million and $5.3 million. Analysts surveyed by FactSet expected $4.5 million. The new guidance would represent a sales jump of between 8.5% and 12.8% from a year ago, when sales came in at $4.7 million.The Nashua, N.H., company noted that it closed 106 deals in the fourth quarter, 19 of which were cloud deals with new and established customers.iCAD, which develops AI-powered technology to detect breast cancer, said it would present at the 12th Annual MedTech, Digital Health, Life Science and Diagnostic Tools Conference taking place in Snowbird, Utah, in February.","collect":0,"end_time":0,"defaultTopTitle":"","property":["earning"],"viewcount":null,"language":"en","relate_stocks":{},"translate_title":"第四季度销售指引超出预期后iCAD股价上涨","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"ICAD":0.9},"content_text":"By Owen Tucker-Smith \n\n\n \n\n\n  iCAD shares jumped after the company issued fourth-quarter sales guidance ahead of Wall Street expectations. \n\n\n  Shares of the medical-device manufacturer were up 17% to $2.82 in Monday trading. The stock price is sitting above its 52-week high and has more than doubled over the past six months. \n\n\n  The company said it expects fourth-quarter revenue between $5.1 million and $5.3 million. Analysts surveyed by FactSet expected $4.5 million. The new guidance would represent a sales jump of between 8.5% and 12.8% from a year ago, when sales came in at $4.7 million. \n\n\n  The Nashua, N.H., company noted that it closed 106 deals in the fourth quarter, 19 of which were cloud deals with new and established customers. \n\n\n  iCAD, which develops AI-powered technology to detect breast cancer, said it would present at the 12th Annual MedTech, Digital Health, Life Science and Diagnostic Tools Conference taking place in Snowbird, Utah, in February. \n\n\n \n\n\n  Write to Owen Tucker-Smith at owen.tucker-smith@wsj.com \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  January 27, 2025 14:12 ET (19:12 GMT)\n\n\n  Copyright (c) 2025 Dow Jones & Company, Inc.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1}}}